Search Results - "Toussirot, E"

Refine Results
  1. 1

    Adiponectin in autoimmune diseases by Toussirot, É, Binda, D, Gueugnon, C, Dumoulin, G

    Published in Current medicinal chemistry (01-11-2012)
    “…Adiponectin is the most abundant adipokine circulating in the organism. Different molecular forms of adiponectin exist: low, middle and high molecular…”
    Get more information
    Journal Article
  2. 2
  3. 3
  4. 4

    Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry by Godot, S., Gottenberg, J.‐E., Paternotte, S., Pane, I., Combe, B., Sibilia, J., Flipo, R.‐M., Schaeverbeke, T., Ravaud, P., Toussirot, E., Berenbaum, F., Mariette, X., Wendling, D., Sellam, J.

    Published in Arthritis care & research (2010) (01-11-2013)
    “…Objective We used data from the AutoImmunity and Rituximab (AIR) registry to investigate the safety of surgery for patients with rheumatoid arthritis receiving…”
    Get full text
    Journal Article
  5. 5

    Eighteen cases of crowned dens syndrome: Presentation and diagnosis by Godfrin-Valnet, M, Godfrin, G, Godard, J, Prati, C, Toussirot, E, Michel, F, Wendling, D

    Published in Neuro-chirurgie (01-06-2013)
    “…Abstract Background and purpose Crowned dens syndrome is an ill-known etiology of acute neck pain. Methods We carried out a retrospective study of 18 cases of…”
    Get full text
    Journal Article
  6. 6

    TNFα blocking agents and sarcoidosis: an update by Toussirot, E, Pertuiset, E

    Published in La revue de medecine interne (01-12-2010)
    “…Increased production of TNFα by alveolar macrophages and involvement of TNFα in granuloma formation suggest that this cytokine is involved in the…”
    Get full text
    Journal Article
  7. 7

    Sarcoidosis occuring during anti-TNF-α treatment for inflammatory rheumatic diseases : report of two cases by TOUSSIROT, E, PERTUISET, E, KANTELIP, B, WENDLING, D

    Published in Clinical and experimental rheumatology (01-05-2008)
    “…Anti-TNF-alpha agents have been tried in cases of refractory sarcoidosis, giving favourable results. Thus, the occurrence of a granulomatous disease in a…”
    Get full text
    Journal Article
  8. 8

    The piriformis muscle syndrome: An exploration of anatomical context, pathophysiological hypotheses and diagnostic criteria by Michel, F, Decavel, P, Toussirot, E, Tatu, L, Aleton, E, Monnier, G, Garbuio, P, Parratte, B

    “…Abstract Introduction The piriformis muscle syndrome (PMS) has remained an ill-defined entity. It is a form of entrapment neuropathy involving compression of…”
    Get full text
    Journal Article
  9. 9

    Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis by Toussirot, Éric, Wendling, Daniel

    Published in Current opinion in rheumatology (01-07-2007)
    “…PURPOSE OF REVIEWBisphosphonates are antiosteoclastic agents widely used in the treatment of bone diseases. They also have antiinflammatory properties…”
    Get full text
    Journal Article
  10. 10

    Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy by Wendling, D, Auge, B, Bettinger, D, Lohse, A, Le Huede, G, Bresson-Hadni, S, Toussirot, E, Miguet, J-P, Herbein, G, Di Martino, V

    Published in Annals of the rheumatic diseases (01-05-2005)
    “…[...]our patient was an asymptomatic HBV carrier, without any increase in serum ALT recorded over a long follow up period. [...]although she received…”
    Get full text
    Journal Article
  11. 11

    Relationship between growth hormone–IGF-I–IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis by Toussirot, ., Nguyen, N. U., Dumoulin, G., Aubin, F., Cédoz, J.-P., Wendling, D.

    Published in Rheumatology (Oxford, England) (01-01-2005)
    “…Objectives. Hormonal factors playing a role in bone mass and body composition have been rarely assessed in rheumatoid arthritis (RA). In this study, we aimed…”
    Get full text
    Journal Article
  12. 12

    Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials [Corrigendum] by Toussirot, Eric, Vauchy, Charline, Binda, Delphine, Michel, Fabrice

    Published in Drug design, development and therapy (01-01-2017)
    “…Toussirot E, Vauchy C, Binda D, Michel F. Drug Des Devel Ther. 2016;10:2087-2094.On page 2089, a column heading in Table 1 was incorrectly presented. The last…”
    Get full text
    Journal Article
  13. 13

    Bone density, ultrasound measurements and body composition in early ankylosing spondylitis by Toussirot, E., Michel, F., Wendling, D.

    Published in Rheumatology (Oxford, England) (01-08-2001)
    “…Objectives. In this cross‐sectional study, we evaluated bone density using both dual‐energy X‐ray absorptiometry (DEXA) and quantitative ultrasound (QUS)…”
    Get full text
    Journal Article
  14. 14

    Characteristics and survival of 26 patients with paraneoplastic arthritis by Morel, J, Deschamps, V, Toussirot, E, Pertuiset, E, Sordet, C, Kieffer, P, Berthelot, J M, Champagne, H, Mariette, X, Combe, B

    Published in Annals of the rheumatic diseases (01-02-2008)
    “…To date, only a few series of patients with paraneoplastic arthritis have been published. The charts of patients with cancer-associated arthritis were…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Piriformis muscle syndrome: Diagnostic criteria and treatment of a monocentric series of 250 patients by Michel, F, Decavel, P, Toussirot, E, Tatu, L, Aleton, E, Monnier, G, Garbuio, P, Parratte, B

    “…Abstract Objectives Piriformis Muscle Syndrome (PMS) is caused by sciatic nerve compression in the infrapiriformis canal. However, the pathology is poorly…”
    Get full text
    Journal Article